Study of phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or in combination for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. [electronic resource]
- Minerva urologica e nefrologica = The Italian journal of urology and nephrology Feb 2020
- 13-21 p. digital
Publication Type: Journal Article; Review
1827-1758
10.23736/S0393-2249.19.03408-8 doi
Adrenergic alpha-Antagonists--adverse effects Drug Therapy, Combination Female Humans Lower Urinary Tract Symptoms--drug therapy Male Phosphodiesterase 5 Inhibitors--adverse effects Prostatic Hyperplasia--drug therapy Quality of Life